Juloori, A.
108  results:
Search for persons X
?
1

Neutrophil-to-Lymphocyte Ratio Kinetics and Survival with N..:

Ji, M. ; Pearson, A. ; Juloori, A....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. e87-e88 , 2024
 
?
2

OA22.03 The Addition of Multisite SBRT to Ipilimumab and Ni..:

Juloori, A. ; Bestvina, C.M. ; Pointer, K.B....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S95-S96 , 2023
 
?
3

Involved Site Radiotherapy in HPV Positive Oropharyngeal Ca..:

Iftekaruddin, Z. ; Huang, D. ; Hara, J....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S68 , 2023
 
?
4

Long-Term Results of Induction Chemotherapy Followed by 50 ..:

Huang, D. ; Rosenberg, A.J. ; Agrawal, N....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S151-S152 , 2023
 
?
5

Radiomics Based Assessment of Tumor Infiltrating CD8 T-Cell..:

Arshad, M. ; Hara, J. ; Iftekaruddin, Z....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e562-e563 , 2023
 
?
6

Predictors of Hepatotoxicity in Patients with Metastatic So..:

Lynch, C. ; Korpics, M.C. ; Katipally, R.R....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. S60 , 2023
 
?
7

Definitive Chemoradiotherapy for Salivary Gland Cancers:

Rajeev-Kumar, G. ; Hara, J. ; Rosenberg, A.J....
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  2 - p. e617-e618 , 2023
 
?
8

EP14.03-001 DARES: A Phase II Trial of Durvalumab and Ablat..:

Juloori, A. ; Gan, G. ; Zhang, J....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S540 , 2022
 
?
9

Assessment of Tumor Burden and Response by RECIST vs. Volum..:

Arshad, M. ; Hara, J. ; Rosenberg, A.J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S113-S114 , 2022
 
?
10

Cell-Free HPV DNA Kinetics Predicted by Radiographic Respon..:

Hara, J. ; Arshad, M. ; Rosenberg, A.J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S22-S23 , 2022
 
?
11

Clinical Factors Associated with Radionecrosis Following St..:

Sivananthan, A.P. ; Korpics, M.C. ; Katipally, R.R....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e63 , 2022
 
?
12

Omission of the Pathologic Node-Negative Neck From Postoper..:

Hara, J. ; Ecanow, N.S. ; Uddin, S....
International Journal of Radiation Oncology*Biology*Physics.  112 (2022)  5 - p. e14 , 2022
 
?
13

Organ Preservation with Definitive Chemoradiotherapy for T4..:

Hara, J. ; Ecanow, N.S. ; Rosenberg, A.J....
International Journal of Radiation Oncology*Biology*Physics.  112 (2022)  5 - p. e25-e26 , 2022
 
?
14

Adverse Events Following Treatment with Combination Ablativ..:

Lynch, C. ; Rosenberg, D.M. ; Korpics, M.C....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S149-S150 , 2022
 
?
15

Radiation Dose and Volume De-Escalation for High-Risk HPV P..:

Iftekaruddin, Z. ; Arshad, M. ; Rosenberg, A.J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S142-S143 , 2022
 
1-15